Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
915851 | Revista Internacional de Andrología | 2016 | 6 Pages |
Abstract
We suggest a PSA index of 17% as cut-off point to discriminate between benign prostatic hyperplasia and prostate cancerin the urology outpatient consult of patients with a total PSA between 4.0 ng/ml and 9.9 ng/ml. We recommend this value as it could reduce the number of negative biopsies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Aranza Pinedo-Pichilingue, Gustavo San MartÃn-San MartÃn, Nilton Yhuri Carreazo,